Compare NTWK & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTWK | CSBR |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.1M | 68.8M |
| IPO Year | 1997 | 2015 |
| Metric | NTWK | CSBR |
|---|---|---|
| Price | $6.02 | $4.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 118.4K | 13.7K |
| Earning Date | 09-28-2026 | 09-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $78,145,875.00 | $2,900,000.00 |
| Revenue This Year | N/A | $9.83 |
| Revenue Next Year | N/A | $8.50 |
| P/E Ratio | $24.16 | ★ N/A |
| Revenue Growth | ★ 6.92 | N/A |
| 52 Week Low | $2.73 | $4.59 |
| 52 Week High | $6.38 | $8.31 |
| Indicator | NTWK | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 77.33 | 48.36 |
| Support Level | $3.05 | $4.74 |
| Resistance Level | N/A | $6.31 |
| Average True Range (ATR) | 0.35 | 0.23 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 84.98 | 22.35 |
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.